Viewpoints

9 Oct 2025

Pharma’s shift away from infectious disease research could spell disaster for the world’s poorest people

STAT

News

3 Oct 2025

DNDi 2025 Projects of the Year recognize contributions of DNDi teams and partners working to deliver urgently needed innovations for people affected by Chagas disease and river blindness

Scientific articles

30 Sep 2025

New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial

BMJ Open

Viewpoints

30 Sep 2025

Drug development for neglected diseases must account for kids

Nature Africa

Viewpoints

30 Sep 2025

Le développement de médicaments pour les maladies négligées doit tenir compte des enfants

Nature Africa

Scientific articles

29 Sep 2025

Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala

Journal of the Brazilian Society of Tropical Medicine

Press releases

23 Sep 2025

Open-science approach delivers a promising pre-clinical candidate for broad-spectrum coronavirus antiviral 

Scientific articles

22 Sep 2025

Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans

Antimicrobial Agents and Chemotherapy

Press releases

15 Sep 2025

Switzerland renews commitment to DNDi to advance medical innovation for neglected patients 

Scientific articles

8 Sep 2025

Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials

The Lancet Microbe

Publications

2 Sep 2025

DNDi Brochure

News

28 Aug 2025

Luke Kanyang’areng becomes first Kenyan to receive Human Rights and Nursing Award